Based on our current knowledge, we propose the following model to explain how dysregulation and dysfunction of RIN3 contributes to AD pathogenesis by impacting intracellular traffic of Rab5 early endosomes; RIN3 activates Rab5 to promote amyloidogenic processing of APP and tau phosphorylation. This evidence concerns the gene MAPT and Alzheimer disease.